Focusing on the innovative application of "peptides", this forum accelerates the empowerment of raw materials in the beauty industry

In order to further promote the exchange and cooperation between peptide ingredient innovation and the cosmetics industry, on August 31, Shenzhen Peptide Shengmei Biotechnology Co., Ltd. (hereinafter referred to as "Peptide Shengmei") held the "Peptide Beauty China·Beauty Industry Peptide Innovation Summit Forum" at Lanzhou Peptide Valley Research Institute. At this meeting, Shenzhen Peptide Sheng Biotechnology Co., Ltd. (hereinafter referred to as "Peptide Sheng Biology"), Lanzhou Peptide Valley Research Institute founder and chief scientist Professor Wang Zhuyin, Air Force General Hospital Dermatology Hospital Director Professor Liu Wei, Sun Yat-sen University Third Dermatology Hospital Professor Lai Wei, Beijing Technology and Business University Professor Zhao Hua, Shanghai Jiaotong University toxicology expert Professor Cheng Shujun, Shanghai University of Applied Technology Professor Zhang Wanping, South China University of Technology Professor Cheng Jianhua, rational skin care movement initiator Dr. Binghan and other authoritative experts explained and shared their views on peptide innovation and development and its application, and conducted in-depth discussions with industry professionals to jointly promote the development of China's cosmetics industry with peptides.

This forum also welcomed the participation of a number of well-known brands and leading raw material manufacturers in the industry, including Pechoin, LVMH, Unilever, LG Health Life, Kao, Amorepacific, Reckitt Benckiser, Mentholatum, Infinitus, HBN, Shanghai Chuanmei, Kangaroo Mom, Shangmei Co., Ltd., Juzi Biotechnology, Huaxi Biotechnology, Pellet Group, Beitani, Xiangyi Bencao, Tisu, New Gaozi, Half Acre Flower Field, Yangshengtang, Coty, and Youshiyan (in no particular order), bringing together the vital forces of all parties in the industrial chain to jointly promote the development and progress of Chinese raw materials.

Professor Liu Wei, former director of the Dermatology Hospital of the Air Force General Hospital

Professor Liu Wei, former director of the Dermatology Hospital of the Air Force General Hospital, said in his speech that the current Chinese raw material industry is showing new development. Relying on the research and development and application of hyaluronic acid, collagen and other fields, Huaxi Biotechnology, Juzi Biotechnology and other companies have achieved a curve overtaking and achieved good development. In fact, for raw material companies, and even the entire cosmetics industry, establishing their own raw material advantages is the top priority.

Professor Liu Wei believes that peptide ingredients have unique advantages in the application of cosmetic raw materials. First, the research and development of peptide ingredient raw materials is still in the early stages, and there are few related raw materials and products on record; second, peptide ingredients are widely used and have good effects in the currently popular fields of anti-aging, whitening and anti-wrinkle; third, the human body itself contains various peptide ingredients, which have high biological safety. With the advancement of cooperation between scientific research institutions and enterprises, peptide raw materials are bound to have a broader development prospect.

Professor Wang Zhuyin, Chief Scientist of Peptide Sheng Biology and Peptide Shengmei

Professor Wang Zhuyin, Chief Scientist of Peptide Sheng Biology and Peptide Shengmei, delivered a keynote speech on the cutting-edge progress of peptide drug technology. At present, the research and development of peptide drugs has become an important outlet, and to promote its application and development, the challenge lies in how to build a feasible peptide library with both sequence diversity and structural diversity. Professor Wang Zhuyin has been committed to peptide research for more than 30 years. He believes that an ideal peptide library must meet three conditions: high sequence diversity, high structural diversity, and non-super mixture. Thanks to his and his team's efforts, Peptide Bio has achieved a curve overtaking in the field of innovative peptide drug discovery, and can provide all-round active peptide molecule discovery CRO services, and play a leading role in the fields of medical beauty active peptides, functional active peptides, etc.

Dr. Gao from Lanzhou Peptide Valley Research Institute

Dr. Gao from Lanzhou Peptide Valley Research Institute gave a keynote speech on "High-throughput screening of peptide libraries: a powerful tool for drug innovation discovery". It is reported that through molecular model screening, cell model screening, small animal model screening and other technologies, Peptide Valley Research Institute has currently screened out a number of active peptides with important clinical therapeutic value.

Dr. Binghan, the initiator of the rational skin care movement

Based on the opportunities in the field of fully innovative functional medical beauty peptides, Dr. Binghan shared the path of the joint efforts of the pharmaceutical and beauty industries. Regarding the current situation and development of the beauty industry, Dr. Binghan mentioned that "at present, in the field of basic raw materials for cosmetics, my country's overall industrial strength is relatively weak, especially for special fine raw materials with small output. However, in the field of functional raw materials, hyaluronic acid and vitamin raw materials are very strong, but there are few varieties and serious internal competition, lack of original and basic research, and generally copying is the main focus." my country's cosmetics industry construction started late. If it wants to catch up with the development of European and American giants, it is essential to study and break through core raw materials and core technologies. Dr. Binghan emphasized that mastering the "Chinese core of raw materials" is the core of cosmetics companies to break through and achieve overtaking on the curve.

It is understood that Peptide Sheng Bio has built a full-process peptide active molecule discovery technology platform for the development of pharmaceutical-grade front-end active peptide raw materials, which is the first in the world and is in a leading position. With its three core technologies of innovative peptide library construction, high-throughput screening, and innovative molecule optimization, Peptide Sheng Bio not only pioneered the "complex structure peptide construction technology" in the world, but also built the world's only "comprehensive" peptide library to avoid the limitations of existing peptide libraries, and also provided specific solutions for the pain points of peptide drug (active peptide) optimization. As an industry team under Peptide Sheng Biology that focuses on the medical beauty track, Peptide Shengmei Biology focuses on the discovery and application of innovative raw materials for peptide cosmetics based on the world's original innovative peptide library technology. It continues to make in-depth efforts in technology, talents, quality control, and efficacy evaluation, introduces cross-disciplinary research, and uses diversified advantages such as standard research and development of innovative drugs to establish solid technical and commercial barriers in market competition, giving full play to the advantages and strengths of Chinese raw material research.

In addition, based on the development of innovative peptide drugs that have been developed, Peptide Sheng Biology and Peptide Shengmei Biology teams further develop innovative cosmetic peptides with innovative drug research and development thinking. Currently, 7 sub-directions have been developed: high-activity, low-toxic, transdermal multicyclic peptides; efficacy molecules "penetrating membrane" and "transdermal" delivery peptides; antibacterial peptides; SNARE Complex inhibitory peptides; active peptides that promote collagen synthesis; tyrosinase inhibitory peptides; melanocyte-targeted peptides, etc., and have achieved many results. Through the world's leading and exclusive peptide innovation technology, it can empower brands and help them build core raw material technical barriers, and jointly promote the high-quality development of China's cosmetics industry.

Tian Longfei, General Manager of Peptide Shengmei

For the co-research and co-creation of peptide products, Tian Longfei, General Manager of Peptide Shengmei, explained the strategic cooperation model. Peptide Shengmei can provide the Chinese beauty industry with co-construction laboratory cooperation, complement resources in the research and development fields such as high-throughput screening, molecular design, mechanism exploration, and efficacy evaluation, and explore innovative points in peptide application; research results can be jointly published as international high-level articles and apply for international invention patents. Enterprises can sign strategic supply contracts and obtain exclusive global authorization for the use of research and development results.

Secondly, Peptide Shengmei can provide customized services according to the needs of enterprises, and provide professional support for the screening of active peptides for specific targets and needs, structural authorization or transfer, and efficient transdermal delivery of traditional efficacy molecules. In addition, Peptide Shengmei has continuously promoted the co-construction of laboratories and the sharing of results through school-enterprise cooperation and strategic customer cooperation, and has obtained the latest results such as super transdermal instant anti-wrinkle peptides. As an innovator of beauty ingredients, Tian Longfei hopes that "Peptide Shengmei is committed to developing the best raw materials in China, empowering Chinese brands, and making the best products in the world!"

The conference also held a seminar on "How medical technology empowers beauty" and a roundtable forum on "Beauty and multidisciplinary cross-applications", inviting Professor Zhao Hua, Secretary-General of the Beijing Daily Chemical Association, Cheng Shujun, Secretary-General of the Shanghai Toxicology Society, Professor Lai Wei of the Dermatology Department of the Third Affiliated Hospital of Sun Yat-sen University, and Zhang Wanping, Executive Dean of the International Cosmetics College of Shanghai University of Applied Technology, and other authoritative experts to discuss the integration and innovation of beauty and related disciplines, and guide the industry towards high-quality development.

It is reported that Shenzhen Peptide Sheng Biotechnology Co., Ltd. and Shenzhen Peptide Shengmei Biotechnology Co., Ltd. were founded by Dr. Wang Zhuyin, a national specially appointed expert and a scientist who has been successful in entrepreneurship. The company has built the world's first entity peptide library that combines peptide structural diversity and sequence diversity, and has built a full-process active peptide discovery technology platform around the peptide library, breaking through the bottleneck of peptide drug discovery and optimization, providing active peptide discovery, screening and optimization services for global biopharmaceutical, health and medical beauty companies, and is committed to innovative peptide product research and development and technology transformation.